Isomorphic Labs

Isomorphic Labs develops AI models and a computational drug design platform for pharmaceutical R&D, working primarily through discovery collaborations and licensing. Founded in 2021 by Alphabet and headquartered in London, the company builds on advances such as AlphaFold to predict and design novel molecules. It has announced multi-year partnerships with Eli Lilly and Novartis to apply its technology to new therapeutics.